CMPS News
-
CMPS bullish
Compass Pathways: The Psilocybin Biotech Leader With Strong Momentum (NASDAQ:CMPS)
seekingalpha.com·Jul 28, 2026·I currently own Compass Pathways ( CMPS ) at about 4.5% of settled NAV, which is about 2% pro-forma after a coming cash influx I have legally due. The company i...
-
CMPS neutral
5 Stocks That Created Fortunes: CMPS +327%, ARWR +222%, CGON +148%, DRTS +182%, ELMD +86%
rttnews.com·Jul 27, 2026·"If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." - Warren Buffett. The Oracle of Omaha's timeless advice re...